Coronavirus tracked: the latest figures as countries fight to contain the pandemic

How six companies are using technology and data to transform themselves Video McKinsey senior partner Kate Smaje joins CEOs to discuss the acceleration of digitization. Special Report The next normal: The recovery will be digital Coronavirus tracked: has your country’s epidemic peaked? Cases or deaths Comparing the spread of coronavirus in different countries is difficult using the data being released by governments. Confirmed case counts depend heavily on the extent of countries’ very different testing regimes, so higher totals may simply reflect more testing. Deaths are somewhat more reliable, but remain problematic because countries have different rules for what deaths to include in their official numbers.

COVID-19 Rapid Evidence Review: Exit through the App Store? Exit through the App Store? A rapid evidence review of the technical considerations and societal implications of using technology to transition from the COVID-19 crisis was undertaken with a view to supporting the Government and the NHS as it adopts technical solutions to aid in the transition from the COVID-19 crisis. Download Exit through the App Store? 1MB Colour PDF The review focuses on three technologies in particular: digital contact tracing, symptom tracking apps and immunity certification. It makes pragmatic recommendations to support well-informed policymaking in response to the crisis.

Coronavirus COVID-19 (2019-nCoV) Lancet Inf Dis Article: Here. Mobile Version: Here. Data sources: Full list. Downloadable database: GitHub, Feature Layer. Lead by JHU CSSE. Technical Support: Esri Living Atlas team and JHU APL. COVID-19: This tool tracks coronavirus's path in Europe While some European countries are easing restrictions, others remain under lockdown. The World Economic Forum created a tool tracking the distinct path of COVID-19 within European countries. Europe is starting down an uneven road to recovery. Denmark is reopening society more quickly than anticipated, and Switzerland is eyeing the easing of emergency measures. Coronavirus (COVID-19) : News, Analysis and Resources The impact of COVID-19, including the closure of certain borders and the disruption of international travel and transport, has shown the risks of economic concentration in certain sectors and demonstrated the renewed importance of strengthening domestic value chains, ensuring food security and improving infrastructure. Investment guides produced by UNCTAD and the International Chamber of Commerce are designed to help governments build their capacity to attract foreign and local investment. They provide investors with essential information on policies, procedures and opportunities that are otherwise scattered across many different websites or outright not available. Being online and easily updatable, staff in investment promotion agencies are able to adapt the guides, while working from home, to refocus promotion efforts to key sectors such as agriculture, agro-processing, manufacturing and infrastructure as they seek to make their economies more resilient and stimulate job creation.

COVID-19 #CoronaVirus Infographic Datapack COVID-19 #Coronavirus latest data visualized. You are welcome to use this graphic in any way you please. » Flattening the Curve (NY Times) and interactive (Washington Post) » World Health Organisation dashboard » All the data in detail (Our World in Data) » How does Corona virus compare with flu? (NY Times) » Coronavirus is very different to Spanish flu (NY Times) » See our beautiful infographic books » Learn how to create impactful infographics & visualisations: online seminars » All our graphics Oxford COVID-19 Evidence Service - CEBM Rapid reviews of primary care questions relating to the coronavirus pandemic, updated regularly. The CEBM has committed its skills and expertise in evidence synthesis and dissemination to the effort against the current COVID-19 pandemic.

COVID-19 Vaccine and Therapeutic Drugs Tracker Clinical trials are the process by which new vaccines and drugs are approved to be used in the general population to help prevent, diagnose, or treat a disease. They are undertaken by healthcare professionals (including researchers and medical doctors) and often fall into five stages. Normally, it takes years or even decades for a compound to pass through clinical trials, but in extraordinary cases (such as pandemics) this process can be sped up to provide medical care to those in need while maintaining the highest standard of safety as well as.